Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients-Reference-Cited by-同舟云学术

Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients

Published:2017-12-06 Issue:4 Volume:20 Page:487-498
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Chen Jing,Cao Shun-Wang,Cai Zhen,Zheng Lei,Wang Qian

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference38 articles.

1. Cancer statistics in China, 2015;Chen;CA: A Cancer Journal for Clinicians,2016

2. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy;Imamura;Journal of Hepatology,2003

3. Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma;Colombo;PloS One,2011

4. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study;Fan;Annals of Surgery,2011

5. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives;Zhang;Seminars in Oncology,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL5 promotes the epithelial-mesenchymal transition of circulating tumor cells in renal cancer;Journal of Translational Medicine;2024-09-03

2. Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma;Journal of Personalized Medicine;2024-04-15

3. Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma;Cells;2023-09-12

4. Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring;International Journal of Molecular Sciences;2023-06-26

5. Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-04-21